| Longleaf Hospice, Llc 2310 Parklake Drive Suite 325, Atlanta, GA, 30345 | |
| (770) 939-9179 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks.
Risk factor modification efforts could help reduce the chance of another heart attack and death among the more than 15 million Americans with coronary heart disease. Yet some patients-especially women and minorities-leave the hospital with poorly managed risk factors.
The Association for Computing Machinery (ACM) awarded its first ACM Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research to a multi-institution research team that included the U.S. Department of Energy's (DOE) Argonne National Laboratory.
A new study finds that a protein key to Parkinson's disease has likely been mischaracterized. The protein, alpha-synuclein, appears to have a radically different structure in healthy cells than previously thought, challenging existing disease paradigms and suggesting a new therapeutic approach.
› Verified 5 days ago
| Name | Longleaf Hospice, Llc |
|---|---|
| Location | 2310 Parklake Drive Suite 325, Atlanta, Georgia |
| Hospice ID | 111680 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Other |
| Profit Type | FOR PROFIT |
| SSA county code | 370 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks.
Risk factor modification efforts could help reduce the chance of another heart attack and death among the more than 15 million Americans with coronary heart disease. Yet some patients-especially women and minorities-leave the hospital with poorly managed risk factors.
The Association for Computing Machinery (ACM) awarded its first ACM Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research to a multi-institution research team that included the U.S. Department of Energy's (DOE) Argonne National Laboratory.
A new study finds that a protein key to Parkinson's disease has likely been mischaracterized. The protein, alpha-synuclein, appears to have a radically different structure in healthy cells than previously thought, challenging existing disease paradigms and suggesting a new therapeutic approach.
› Verified 5 days ago
| NPI Number | 1427206960 |
| Organization Name | Longleaf Hospice, Llc |
| Address | 2712 Lawrenceville Hwy Decatur, Georgia, 30033 |
| Phone Number | (770)939-9179 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks.
Risk factor modification efforts could help reduce the chance of another heart attack and death among the more than 15 million Americans with coronary heart disease. Yet some patients-especially women and minorities-leave the hospital with poorly managed risk factors.
The Association for Computing Machinery (ACM) awarded its first ACM Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research to a multi-institution research team that included the U.S. Department of Energy's (DOE) Argonne National Laboratory.
A new study finds that a protein key to Parkinson's disease has likely been mischaracterized. The protein, alpha-synuclein, appears to have a radically different structure in healthy cells than previously thought, challenging existing disease paradigms and suggesting a new therapeutic approach.
› Verified 5 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.7 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 87.9 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 93.4 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 78.6 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.8 | 97.3 |
| Patients who got timely treatment for shortness of breath | 71.9 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 82.6 | 93.3 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks.
Risk factor modification efforts could help reduce the chance of another heart attack and death among the more than 15 million Americans with coronary heart disease. Yet some patients-especially women and minorities-leave the hospital with poorly managed risk factors.
The Association for Computing Machinery (ACM) awarded its first ACM Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research to a multi-institution research team that included the U.S. Department of Energy's (DOE) Argonne National Laboratory.
A new study finds that a protein key to Parkinson's disease has likely been mischaracterized. The protein, alpha-synuclein, appears to have a radically different structure in healthy cells than previously thought, challenging existing disease paradigms and suggesting a new therapeutic approach.
› Verified 5 days ago
| Home Health Aides | 9.75 |
| Counselors | 1.5 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 3 |
| Physicians | 1 |
| Registered Nurses | 15.5 |
| Other Personnel | 15 |
| Total Employees | 47.75 |
|---|
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks.
Risk factor modification efforts could help reduce the chance of another heart attack and death among the more than 15 million Americans with coronary heart disease. Yet some patients-especially women and minorities-leave the hospital with poorly managed risk factors.
The Association for Computing Machinery (ACM) awarded its first ACM Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research to a multi-institution research team that included the U.S. Department of Energy's (DOE) Argonne National Laboratory.
A new study finds that a protein key to Parkinson's disease has likely been mischaracterized. The protein, alpha-synuclein, appears to have a radically different structure in healthy cells than previously thought, challenging existing disease paradigms and suggesting a new therapeutic approach.
› Verified 5 days ago
| Others | 33 |
| Total Volunteers | 33 |
|---|
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks.
Risk factor modification efforts could help reduce the chance of another heart attack and death among the more than 15 million Americans with coronary heart disease. Yet some patients-especially women and minorities-leave the hospital with poorly managed risk factors.
The Association for Computing Machinery (ACM) awarded its first ACM Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research to a multi-institution research team that included the U.S. Department of Energy's (DOE) Argonne National Laboratory.
A new study finds that a protein key to Parkinson's disease has likely been mischaracterized. The protein, alpha-synuclein, appears to have a radically different structure in healthy cells than previously thought, challenging existing disease paradigms and suggesting a new therapeutic approach.
› Verified 5 days ago
| Hospice Atlanta Location: 1244 Park Vista Dr., Atlanta, Georgia, 30319 Phone: (770) 939-9179 |
| Aseracare Hospice Location: 1117 Perimeter Center West, Suite N500, Atlanta, Georgia, 30338 Phone: (770) 939-9179 |
| Gentiva Hospice Location: 3101 Towercreek Pkwy Se Suite 225, Atlanta, Georgia, 30339 Phone: (770) 939-9179 |
| Vitas Healthcare Corporation Of Georgia Location: 1575 Northside Drive, Suite 375, Atlanta, Georgia, 30318 Phone: (770) 939-9179 |